Infection prevention products and services will be worth US$24.6bn in the US by 2018, reveals study
Protective clothing and textiles will lead revenue in drive to reduce risk of hospital-acquired infections
US demand for infection prevention products and services will expand 4.8% annually to US$24.6bn in 2018 according to a new report from Freedonia.
Bill Martineau, an analyst at the Cleveland, Ohio, US-based market research company, said that the increasing enforcement of safeguards aimed at reducing the incidence of healthcare-associated infections (HAIs) in medical settings will help boost the market.
The upgrading of quality control and quality assurance standards in life science research and pharmaceutical and medical device production facilities will also contribute to growth.
According to the report, Infection Prevention Products & Services, demand for infection prevention supplies will increase 4.7% annually to $18.6bn in 2018. Protective clothing and textiles will top revenue ($7.31bn) as hospitals aim to reduce the risk of HAIs in surgery. Other invasive procedures are expected to broaden the use of premium, barrier enhanced gloves, drapes, gowns, face masks, and other clothing and textiles.
Safety enhanced medical devices will post the fastest growth in demand among infection prevention supplies (reaching $5.75bn in 2018, a rise of 5.7%) as medical providers seek to improve the safety of blood collection, catheterisation, drug delivery, and invasive surgical procedures.
Total demand for infection prevention equipment is forecast to expand 2.9% annually to $990m in 2018, says the report. Efforts by the healthcare and life science sectors to keep up with advancing infection prevention technologies and capabilities will increase growth prospects for sterilisation, washing/disinfecting, infectious waste disposal, and various other equipment such as scrub stations, incubators and ultrasonic cleaners.
Convenience, cost, and regulatory compliance advantages will expand the US market for infection prevention services by 5.6% annually to $4.97bn.
Infectious waste disposal services will dominate demand as government restrictions on onsite incineration remain and force health facilities to use outside firms for infectious waste collection and disposal.